XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB)

Historical Portfolio Holders from Q1 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPONSORED ADR NE
Shares, excl. options Q2 2024
253K
Holdings value Q2 2024
$613K
Value change Q2 2024
-$16.7K
Grand Portfolio weight change Q2 2024
0%
Number of holders
4
Number of buys Q2 2024
2
Number of sells Q2 2024
-2
Average buys Q2 2024 %
0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 253K $613K -$16.7K $2.40 4
2024 Q1 259K $728K +$57.5K $2.81 5
2023 Q4 239K $242K +$136 $1.01 5
2023 Q3 240K $216K -$431 $0.90 4
2023 Q2 240K $240K -$600 $1.00 3
2023 Q1 241K $316K -$1.94K $1.31 2
2022 Q4 242K $293K -$2.42K $1.21 3
2022 Q3 443K $492K -$3.87K $1.11 3
2022 Q2 447K $678K -$2.76K $1.52 3
2022 Q1 448K $1.05M -$65.7K $2.37 4
2021 Q4 472K $1.31M -$67.9K $2.77 4
2021 Q3 487K $2.14M -$54K $4.38 6
2021 Q2 501K $2M -$29.2K $3.99 5
2021 Q1 509K $1.69M +$115K $3.33 6
2020 Q4 474K $1.44M +$85.4K $3.03 4
2020 Q3 446K $848K +$12.6K $1.90 4
2020 Q2 440K $699K +$3.04K $1.59 3
2020 Q1 438K $515K +$3.65K $1.18 3
2019 Q4 435K $594K -$60.1K $1.37 3
2019 Q3 481K $687K +$25.8K $1.43 6
2019 Q2 463K $927K -$2.96K $2.00 5
2019 Q1 465K $1.1M +$964 $2.36 5
2018 Q4 465K $804K -$65.7K $1.73 6
2018 Q3 97.5K $208K -$10.8K $2.20 4
2018 Q2 104K $193K +$114K $1.85 4
2018 Q1 44K $76K +$11.4K $1.75 4
2017 Q4 36.7K $84K -$23.3K $2.30 2
2017 Q3 49.7K $118K +$2.45K $2.36 4
2017 Q2 48.9K $155K +$38.5K $3.16 3
2017 Q1 36.8K $97K +$97K $2.63 3